Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng Mi

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
ACS Nano|April 17, 2015
Systemic Targeting of Lymph Node Metastasis through the Blood Vascular System by Using Size-Controlled NanocarriersHoracio Cabral, Jun Makino, Yu Matsumoto, et al.
ACS Nano|August 19, 2014
Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticlesHyun Jin Kim, Hiroyasu Takemoto, Yu Yi, et al.
Journal for Immunotherapy of Cancer|June 18, 2026
Integrin CD11b/CD18 reprograms macrophage polarization by suppressing ERK/STAT3 signaling to enhance antitumor immunity in colitis-associated colorectal cancerYing Lin, Yuan-Kun Liu, Peng Mi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 15, 2019
Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cellsYu Yi, Hyun Jin Kim, Meng Zheng, et al.
Journal of Cancer Research and Clinical Oncology|December 10, 2015
In vivo evaluation of neutron capture therapy effectivity using calcium phosphate-based nanoparticles as Gd-DTPA delivery agentNovriana Dewi, Peng Mi, Hironobu Yanagie, et al.
Nature Cancer|January 29, 2026
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecanJing Xu, Jing Liu, Yang Liu, et al.
Theranostics|June 14, 2018
Negative regulation of cationic nanoparticle-induced inflammatory toxicity through the increased production of prostaglandin E2 via mitochondrial DNA-activated Ly6C<sup>+</sup> monocytesLi Liu, Yantong Liu, Bocheng Xu, et al.
Theranostics|September 20, 2019
Erratum: Negative regulation of cationic nanoparticle-induced inflammatory toxicity through the increased production of prostaglandin E2 via mitochondrial DNA-activated Ly6C<sup>+</sup> monocytes: ErratumLi Liu, Yantong Liu, Bocheng Xu, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
ACS Nano|April 17, 2015
Systemic Targeting of Lymph Node Metastasis through the Blood Vascular System by Using Size-Controlled NanocarriersHoracio Cabral, Jun Makino, Yu Matsumoto, et al.
ACS Nano|August 19, 2014
Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticlesHyun Jin Kim, Hiroyasu Takemoto, Yu Yi, et al.
Journal for Immunotherapy of Cancer|June 18, 2026
Integrin CD11b/CD18 reprograms macrophage polarization by suppressing ERK/STAT3 signaling to enhance antitumor immunity in colitis-associated colorectal cancerYing Lin, Yuan-Kun Liu, Peng Mi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 15, 2019
Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cellsYu Yi, Hyun Jin Kim, Meng Zheng, et al.
Journal of Cancer Research and Clinical Oncology|December 10, 2015
In vivo evaluation of neutron capture therapy effectivity using calcium phosphate-based nanoparticles as Gd-DTPA delivery agentNovriana Dewi, Peng Mi, Hironobu Yanagie, et al.
Nature Cancer|January 29, 2026
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecanJing Xu, Jing Liu, Yang Liu, et al.
Theranostics|June 14, 2018
Negative regulation of cationic nanoparticle-induced inflammatory toxicity through the increased production of prostaglandin E2 via mitochondrial DNA-activated Ly6C<sup>+</sup> monocytesLi Liu, Yantong Liu, Bocheng Xu, et al.
Theranostics|September 20, 2019
Erratum: Negative regulation of cationic nanoparticle-induced inflammatory toxicity through the increased production of prostaglandin E2 via mitochondrial DNA-activated Ly6C<sup>+</sup> monocytes: ErratumLi Liu, Yantong Liu, Bocheng Xu, et al.
Pageof 9